5 sources checked · Left, Center, and Right included · 1h ago
Still Watching
Eli Lilly: Next-gen weight loss drug may be more effective than others
Eli Lilly says next-generation weight loss drug clears crucial obesity trial. “The highest dose of retatrutide helped patients lose 28.3% of their weight — or 70.3 pounds — on average over 80 weeks.”
2 Left2 Center1 Right
Still watching.Optics is waiting for a cleaner match before calling the split.
STILL WATCHING
As of May 21, 2026 at 7:51 PM, this is how Optics News reads the wording differences in this story.
What happenedEli Lilly's weight loss drug retatrutide helped nearly half of participants in a phase 3 trial to lose more than 30% of their weight after two years.
The headline splitOne side frames it as "A Next-Generation Drug Causes Dramatic Weight Loss, Eli Lilly Says". The other frames it as "Eli Lilly says next-generation weight loss drug clears crucial obesity trial. “The".
Can I trust it?Not yet. The match is still developing.
WHAT EACH SIDE EMPHASIZED
Left / center-leftA Next-Generation Drug Causes Dramatic Weight Loss, Eli Lilly Says
Time · Center-left · News report
CenterEli Lilly: Next-gen weight loss drug may be more effective than others
UPI · Center · Wire story
Right / center-rightEli Lilly says next-generation weight loss drug clears crucial obesity trial. “The
AND ANOTHER ONE: Eli Lilly says next-generation weight loss drug clears crucial obesity trial. “The
anotherlilly
Eli Lilly says next-generation weight loss drug clears crucial obesity trial. “The highest dose of retatrutide helped patients lose 28.3% of their weight — or 70.3 pounds — on average over...
STAT+: Pharmalittle: We’re reading about a Lilly obesity drug trial, statistics for an Alzheimer’s drug, and more
Eli Lilly reported that in a late-stage trial, its next-generation obesity drug led to weight loss approaching the effectiveness seen with bariatric surgery
